U.S. Representative Billy Long ( R-MO 7th District) has introduced legislation to update regulations guiding how drug manufacturers communicate product information. Long is the lead sponsor of H.R. 2479, which would ensure the FDA clearly regulated meaningful, truthful and non-misleadinOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.